Skip to content
Search
About Us
About Us
Subscribe
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Home
News
All News
Artificial Intelligence
Biosimilars
Clinical Trials
COVID
Diagnostics
Disease Indications
FDA Updates
Immune Globulin
Influenza
Insurance Reimbursement
Medicare
Medicines
Therapeutics
Vaccines
Washington Report
Industry Insight
All Industry Insight
Artificial Intelligence
Biosimilars
Chronic Illness
COVID
Disease Indications
Drug Safety
Gene Therapy
Immune Globulin
Influenza
Innovation & Discovery
Insurance Reimbursement
Manufacturing
Myths & Facts
Patient Safety
Plasma
Research & Development
Telehealth
Therapeutics
Vaccines
Operations & Management
All Operations & Management
Artificial Intelligence
Drug Safety
Drug Shortages
Healthcare Management
Insurance Reimbursement
Reimbursement FAQs
Service & Safety
Staffing
Perspectives
All Perspectives
BSTQ&A
Leadership Corner
Patient Focus
Pharma5
Provider Focus
Resources
Available Resources
BioSupply Trends eNewsletter
Issues
Current Issue
Past Issues
Subscribe
About Us
Search
Winter 2020 - Integrated Care
Download Issue
Share
Up Front
Publisher's Corner
The Challenges of Drug Accessibility
By Patrick M. Schmidt
Features
The Current Challenge of Immune Globulin Access
By
Ronale Tucker Rhodes, MS
Myths & Facts: Bipolar Spectrum Disorder
By
Jim Trageser
Update on Anaphylaxis
By
Diane L.M. Cook
Establishing an Antimicrobial Stewardship Program
By
Amy Scanlin, MS
Short-Dated Products: Reducing Unsalable Returns and Supply Chain Waste
By
Trudie Mitschang
A Guide to Immune Globulin Billing and Reimbursement
By
Show No Author
BioTrends Watch
Washington Report
CMS Enacts Medicare, Medicaid and CHIP Fraud-Fighting Rules
CMS Finalizes Rule for Programs of All-Inclusive Care for the Elderly
FDA Issues Final Guidance on Biosimilar Interchangeability
CMS Finalizes Rule for Cuts to Medicaid DSH Payments
$1 Billion Grant Awarded to Fight Addiction and Chronic Pain
Reimbursement FAQs
Complying with Rules Ensures Reimbursement for Drugs
Healthcare Management
Internet of Things (IoT) in the Healthcare Setting
Industry News
NIH to Evaluate Experimental Adjuvants for Seasonal Influenza Vaccine
New Rabies Calculator Helps Providers Treat Patients Exposed to Rabies
Octapharma Introduces New SCIG Product and IgCares Program
FDA Approves Octaplas to Treat Pediatric Patients Who Require Multiple Coagulation Factor Replacement
HPV Vaccine Exceeds Expectations by Providing Herd Immunity
Researchers Discover New, Rare Autoimmune Disease
BioFocus
Industry Insight
Secondary Antibody Deficiency
By Keith Berman, MPH, MBA
Patient Profile
Bipolar Disorder: A Patient's Perspective
By Trudie Mitschang
Physician Profile
Bipolar Disorder: A Physician's Perspective
By Trudie Mitschang
BioSources
BioResearch
Anti-Influenza Hyperimmune Immune Globulin Not Effective in Hospitalized Adults with Influenza Infection
Emicizumab Prophylaxis Combined with ITI Effective in Pediatric Patients with Severe Hemophilia A and Inhibitors